Source: Monsanto Company

Monsanto Company and Atlas Venture, an early-stage venture capital firm based in Cambridge, Mass., announced an agreement to enter a multi-year collaboration to explore investment opportunities in early-stage life sciences technology companies.

Under the agreement, Monsanto will work with Atlas to identify strategic investments in a number of technology focus areas within agriculture to support and complement Monsanto's interests and potential growth areas, including genomics, informatics and biology. For Atlas, this collaboration provides access to technology capabilities and insight that bring a unique perspective to its investment process. 

Original news release